Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Rheumatology|April 12, 2001
The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulideP Sarzi-Puttini, S Santandrea, L Boccassini, et al.
Reumatismo|September 10, 2016
Possible relationship between certolizumab pegol and arrhythmias: report of two casesR Talotta, F Atzeni, A Batticciotto, et al.
Clinical and Experimental Rheumatology|January 17, 2012
Fibromyalgia: a critical digest of the recent literatureL Bazzichi, F Sernissi, A Consensi, et al.
Lupus|October 13, 2005
Cardiac imaging techniques in systemic autoimmune diseasesM Turiel, R Peretti, P Sarzi-Puttini, et al.
Reumatismo|June 19, 2014
Physiopathology of pain in rheumatologyM Cazzola, F Atzeni, L Boccassini, et al.
The Journal of International Medical Research|March 1, 1993
A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndromeS Santandrea, F Montrone, P Sarzi-Puttini, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin AF Atzeni, P Sarzi-Puttini, F Capsoni, et al.
La Chirurgia Degli Organi Di Movimento|October 1, 1990
The treatment of idiopathic and secondary hydrarthrosis of the knee by intra-articular Rifamycin SVG Setti, C A Calciolari, V Cimino, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3P Sarzi-Puttini, F Atzeni, J Schölmerich, et al.
The Open Rheumatology Journal|June 2, 2012
Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid ArthritisM Benucci, G Saviola, P Baiardi, et al.
Pageof 12